SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 408 filers reported holding SHOCKWAVE MED INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,507,066 | -28.9% | 37,705 | +1.9% | 0.02% | -21.7% |
Q2 2023 | $10,564,452 | +380.7% | 37,015 | +265.2% | 0.02% | +360.0% |
Q1 2023 | $2,197,572 | -1.8% | 10,135 | -6.9% | 0.01% | 0.0% |
Q4 2022 | $2,238,065 | -28.4% | 10,885 | -3.2% | 0.01% | -37.5% |
Q3 2022 | $3,127,000 | +42.2% | 11,245 | -2.3% | 0.01% | +60.0% |
Q2 2022 | $2,199,000 | -9.2% | 11,505 | -1.5% | 0.01% | 0.0% |
Q1 2022 | $2,421,000 | +16.3% | 11,675 | 0.0% | 0.01% | +25.0% |
Q4 2021 | $2,082,000 | -13.5% | 11,675 | -0.2% | 0.00% | -20.0% |
Q3 2021 | $2,408,000 | +11.9% | 11,698 | +3.2% | 0.01% | +25.0% |
Q2 2021 | $2,151,000 | +67.5% | 11,338 | +15.0% | 0.00% | +33.3% |
Q1 2021 | $1,284,000 | +31.7% | 9,860 | +4.9% | 0.00% | +50.0% |
Q4 2020 | $975,000 | +52.6% | 9,400 | +11.5% | 0.00% | +100.0% |
Q3 2020 | $639,000 | +74.6% | 8,430 | +9.2% | 0.00% | 0.0% |
Q2 2020 | $366,000 | – | 7,720 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
Matisse Capital | 22,175 | $4,415,043 | 3.12% |
Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
AtonRa Partners | 4,374 | $870,863 | 1.83% |
Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |